Baxter International Financial Statements (BAX)

Baxter Internationalsmart-lab.ru %   2019 2020 2021 2022 2023   LTM ?
Report date 17.03.2020 11.02.2021 23.02.2022 09.02.2023 08.02.2024   02.05.2024
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 11 362 11 673 12 784 15 113 14 813   14 892
Operating Income, bln rub 976.0 603.0 779.0 -549.0 390.0   593.0
EBITDA, bln rub ? 1 765 1 426 1 669 854.0 1 751   1 654
Net profit, bln rub ? 1 001 1 102 1 284 -2 421 2 656   2 649
OCF, bln rub ? 2 104 1 868 2 222 1 211 1 726   1 410
CAPEX, bln rub ? 696.0 709.0 743.0 679.0 692.0   696.0
FCF, bln rub ? 1 408 1 159 1 479 532.0 1 034   714.0
Dividend payout, bln rub 423.0 473.0 530.0 573.0 586.0   587.0
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 42.3% 42.9% 41.3% 0.00% 22.1%   22.2%
OPEX, bln rub 3 885 2 971 3 395 4 528 4 563   4 420
Cost of production, bln rub 6 601 7 086 7 679 9 716 9 838   9 844
R&D, bln rub 595.0 521.0 534.0 605.0 667.0   663.0
Interest expenses, bln rub 111.0 134.0 192.0 395.0 512.0   480.0
Assets, bln rub 18 193 20 019 33 521 28 287 28 276   27 788
Net Assets, bln rub ? 7 882 8 689 9 077 5 833 8 402   8 173
Debt, bln rub 5 961 6 804 18 310 17 213 14 364   14 170
Cash, bln rub 3 335 3 730 2 951 1 718 3 198   3 026
Net debt, bln rub 2 626 3 074 15 359 15 495 11 166   11 144
Ordinary share price, rub 83.6 80.2 85.8 51.0 38.7   34.2
Number of ordinary shares, mln 509.0 509.0 502.0 504.0 506.0   508.0
Market cap, bln rub 42 563 40 842 43 092 25 689 19 562   17 374
EV, bln rub ? 45 189 43 916 58 451 41 184 30 728   28 518
Book value, bln rub 3 381 3 801 -8 551 -7 803 -4 191   -4 162
EPS, rub ? 1.97 2.17 2.56 -4.80 5.25   5.21
FCF/share, rub 2.77 2.28 2.95 1.06 2.04   1.41
BV/share, rub 6.64 7.47 -17.0 -15.5 -8.28   -8.19
EBITDA margin, % ? 15.5% 12.2% 13.1% 5.65% 11.8%   11.1%
Net margin, % ? 8.81% 9.44% 10.0% -16.0% 17.9%   17.8%
FCF yield, % ? 3.31% 2.84% 3.43% 2.07% 5.29%   4.11%
ROE, % ? 12.7% 12.7% 14.1% -41.5% 31.6%   32.4%
ROA, % ? 5.50% 5.50% 3.83% -8.56% 9.39%   9.53%
P/E ? 42.5 37.1 33.6 -10.6 7.37   6.56
P/FCF 30.2 35.2 29.1 48.3 18.9   24.3
P/S ? 3.75 3.50 3.37 1.70 1.32   1.17
P/BV ? 12.6 10.7 -5.04 -3.29 -4.67   -4.17
EV/EBITDA ? 25.6 30.8 35.0 48.2 17.5   17.2
Debt/EBITDA 1.49 2.16 9.20 18.1 6.38   6.74
R&D/CAPEX, % 85.5% 73.5% 71.9% 89.1% 96.4%   95.3%
CAPEX/Revenue, % 6.13% 6.07% 5.81% 4.49% 4.67%   4.67%
Baxter International shareholders